Stock Research for ONTX


Featured Broker: Ally Invest

Get the due diligence for another stock.


ONTX Stock Chart & Research Data

The ONTX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ONTX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ONTX Due diligence Resources & Stock Charts

The ONTX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ONTX Detailed Price Forecast - CNN Money CNN View ONTX Detailed Summary - Google Finance
Yahoo View ONTX Detailed Summary - Yahoo! Finance Zacks View ONTX Stock Research & Analysis -

Stock Analysis

TradeIdeas View ONTX Trends & Analysis - Trade-Ideas Barrons View ONTX Major Holders - Barrons
NASDAQ View ONTX Call Transcripts - NASDAQ Seeking View ONTX Breaking News & Analysis - Seeking Alpha
Spotlight View ONTX Annual Report - OTC Report View ONTX OTC Short Report -
TradeKing View ONTX Fundamentals - TradeKing Charts View ONTX SEC Filings - Bar Chart
WSJ View Historical Prices for ONTX - The WSJ Morningstar View Performance/Total Return for ONTX - Morningstar
MarketWatch View the Analyst Estimates for ONTX - MarketWatch CNBC View the Earnings History for ONTX - CNBC
StockMarketWatch View the ONTX Earnings - StockMarketWatch MacroAxis View ONTX Buy or Sell Recommendations - MacroAxis
Bullish View the ONTX Bullish Patterns - American Bulls Short Pains View ONTX Short Pain Metrics -

Social Media Mentions

StockTwits View ONTX Stock Mentions - StockTwits PennyStocks View ONTX Stock Mentions - PennyStockTweets
Twitter View ONTX Stock Mentions - Twitter Invest Hub View ONTX Investment Forum News - Investor Hub
Yahoo View ONTX Stock Mentions - Yahoo! Message Board Seeking Alpha View ONTX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ONTX - Insider Cow View Insider Transactions for ONTX - Insider Cow
CNBC View ONTX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ONTX - OTC Markets
Yahoo View Insider Transactions for ONTX - Yahoo! Finance NASDAQ View Institutional Holdings for ONTX - NASDAQ

Stock Charts

FinViz View ONTX Stock Insight & Charts - StockCharts View ONTX Investment Charts -
BarChart View ONTX Stock Overview & Charts - BarChart Trading View View ONTX User Generated Charts - Trading View

Latest Financial News for ONTX

Edited Transcript of ONTX earnings conference call or presentation 14-Aug-18 1:00pm GMT
Posted on Tuesday August 21, 2018

Q2 2018 Onconova Therapeutics Inc Earnings Call

Onconova Therapeutics Announces Plan for Expanding Rigosertib Clinical Trials for Patients with Myelodysplastic Syndromes (MDS) to South America with Pint Pharma
Posted on Tuesday August 21, 2018

Onconova Therapeutics, Inc. (ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on myelodysplastic syndromes (MDS), today announced that its commercial partner, Pint Pharma GmbH, will assist in expanding access to clinical trials studying rigosertib, a novel and targeted anti-cancer compound currently in a Phase 3 study for the treatment of MDS, to several selected sites across South America. Pint Pharma is a European-based pharmaceutical company focused on the development, registration and commercialization of specialty-based treatments for the Latin American market and has successfully participated in clinical trials for hematological cancers.

Onconova Therapeutics Reports Business Highlights and Financial Results for Second Quarter 2018
Posted on Tuesday August 14, 2018

NEWTOWN, Pa., Aug. 14, 2018-- Onconova Therapeutics, Inc., a Phase 3 stage biopharmaceutical company focused on developing rigosertib, a novel small molecule drug candidate to treat cancer, with a primary ...

Onconova Therapeutics Inc. to Host Earnings Call
Posted on Tuesday August 14, 2018

NEW YORK, NY / ACCESSWIRE / August 14, 2018 / Onconova Therapeutics Inc. (NASDAQ: ONTX ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 14, 2018 at 9:00 AM Eastern ...

Stock Market & Investing Books

Enter a stock symbol to view the stock details.